Prescription drugs are among the least predictable costs in retirement, swinging with each new diagnosis and formulary change. A federal subsidy called Extra Help removes most of that uncertainty for lower-income Medicare beneficiaries: it eliminates the Part D deductible, holds copayments to a few dollars, and caps the price of a brand-name drug at $12.65 in 2026. The Social Security Administration estimates the benefit is worth roughly $6,000 a year, yet a substantial share of the people who qualify have never applied for it.
What Extra Help strips out of a Part D bill
The subsidy works by dismantling the ordinary Part D cost structure piece by piece. Enrollees pay no annual deductible, so coverage begins with the first prescription rather than after hundreds of dollars in spending. Copayments are then fixed at low, predictable amounts — $5.10 for a generic and $12.65 for a brand-name drug in 2026 — instead of the percentage coinsurance that can make a single specialty medication cost hundreds of dollars a fill.
Extra Help also covers the Part D premium up to a regional benchmark, meaning many enrollees pay nothing for the plan itself. And because the subsidy carries beneficiaries through the year at those fixed copays, it neutralizes the coverage phases that trip up other enrollees, including the new annual out-of-pocket cap that unsubsidized beneficiaries must spend their way toward before their own costs stop.
The result is a drug bill that behaves like a small, flat fee rather than a variable expense. For someone taking several maintenance medications, the difference between paying a percentage of an expensive drug’s price and paying a $12.65 ceiling is the difference between rationing doses and filling every prescription on schedule.
Free retirement updates: One number can cost or save hundreds a month in retirement. The free Retirement Shield newsletter surfaces the ones worth knowing. Sign up free.
Who qualifies, and the automatic door in
Eligibility turns on income and resources. The subsidy is generally available to beneficiaries with income up to 150 percent of the federal poverty level and limited assets, thresholds that reach higher up the income scale than many people assume. A 2024 change eliminated the old partial subsidy and extended the full benefit to everyone under that ceiling, so there is no longer a reduced tier for applicants to fall into.
Some people never have to apply at all. Anyone already enrolled in Medicaid, Supplemental Security Income, or a Medicare Savings Program is automatically enrolled in Extra Help, with no separate paperwork required. For everyone else, the application runs through Social Security and can be filed online, and an approval stays in force as long as the person keeps meeting the limits rather than expiring after a single year.
What a standard 2026 Part D plan charges instead
The savings come into focus against the plan an unsubsidized beneficiary actually faces. A standard 2026 Part D plan can impose a deductible of as much as $615 before coverage starts, then charge 25 percent coinsurance on each drug until a person’s spending reaches the $2,100 catastrophic threshold. Extra Help demolishes that entire ladder: no deductible, no percentage coinsurance, and no long climb toward a cap, all replaced by the flat copays that hold steady whatever the drug’s list price.
Getting the subsidy is not always a matter of applying. A beneficiary enrolled in Medicaid, Supplemental Security Income, or a Medicare Savings Program is “deemed” into Extra Help automatically, while everyone else files the Social Security application known as the SSA-1020, online or through a local office. Eligibility rests on both an income test set at 150 percent of the poverty level and a separate limit on countable resources that excludes a primary home and one car.
The subsidy is not a one-time award. Social Security periodically redetermines eligibility, and deemed status resets each year based on whether a person still holds Medicaid, SSI, or a savings program, so a change in circumstances can add or remove the benefit. The countable-resource ceilings that gate the full subsidy are updated annually for 2026, which is why an applicant turned away in a prior year on assets alone may qualify once the limits rise.
Why the $12.65 cap matters more than it looks
The brand-name ceiling is where the subsidy quietly does its heaviest work. Many drugs that treat common conditions in older adults — blood thinners, insulin, inhalers, and newer specialty medications — carry list prices and coinsurance that can run into the hundreds of dollars a month without help. Capping the enrollee’s share at $12.65 turns an otherwise unaffordable prescription into a routine expense that fits inside a fixed monthly budget.
The arithmetic makes the gap vivid. Under a standard plan’s 25 percent coinsurance, a brand-name drug with a $600 list price costs the enrollee about $150 for a single monthly fill; under Extra Help that same fill is capped at $12.65. Across several maintenance medications, the difference compounds into thousands of dollars a year — the margin that decides whether a fixed-income household fills every prescription or starts stretching pills to make a bottle last.
That is the reason the low take-up is so costly. Because the savings appear only for people who actually enroll, the seniors most exposed to high drug prices are also the ones most likely to be leaving the protection unused, sometimes while skipping medications they cannot afford at full cost. The figure to remember is deliberately small — $12.65 — but it stands between a fixed-income household and drug bills that can otherwise force a choice between filling a prescription and covering another necessity.
This article was produced with AI assistance and reviewed against primary sources by The Money Overview editorial team.
More Financial Reading
